Works about HODGKIN'S disease treatment


Results: 751
    1
    2

    Decision-Making among Experts in Advanced Hodgkin Lymphoma.

    Published in:
    Oncology, 2023, v. 101, n. 3, p. 159, doi. 10.1159/000526360
    By:
    • Hitz, Felicitas;
    • Lang, Noémie;
    • Mey, Ulrich;
    • Mingrone, Walter;
    • Moccia, Alden;
    • Taverna, Christian;
    • Novak, Urban;
    • Stenner, Frank;
    • Schmidt, Adrian;
    • Mamot, Christoph;
    • Fischer, Natalie;
    • Putora, Paul M.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Management of Hodgkin's lymphoma in Latin America.

    Published in:
    Journal of Alternative Medicine Research, 2019, v. 11, n. 4, p. 389
    By:
    • Ferrigno, Lívia Alvarenga Fagundes;
    • Marta, Gustavo Nader;
    • Lim, Fiona;
    • Wan, Bo Angela;
    • Silva, Mauricio F.
    Publication type:
    Article
    14
    15

    Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease.

    Published in:
    JAMA: Journal of the American Medical Association, 2003, v. 290, n. 4, p. 465, doi. 10.1001/jama.290.4.465
    By:
    • Travis, Lois B.;
    • Hill, Deirdre A.;
    • Dores, Graça M.;
    • Gospodarowicz, Mary;
    • van Leeuwen, Flora E.;
    • Holowaty, Eric;
    • Glimelius, Bengt;
    • Andersson, Michael;
    • Wiklund, Tom;
    • Lynch, Charles F.;
    • Van't Veer, Mars B.;
    • Glimelius, Ingrid;
    • Storm, Hans;
    • Pukkala, Eero;
    • Stovall, Marilyn;
    • Curtis, Rochelle;
    • Boice, Jr, John D.;
    • Gilbert, Ethel
    Publication type:
    Article
    16
    17

    Erratum.

    Published in:
    2011
    Publication type:
    Correction Notice
    18
    19

    Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.

    Published in:
    European Journal of Haematology, 2011, v. 86, n. 2, p. 117, doi. 10.1111/j.1600-0609.2010.01552.x
    By:
    • Nagai, Hirokazu;
    • Ogura, Michinori;
    • Kusumoto, Shigeru;
    • Takahashi, Naoto;
    • Yamaguchi, Motoko;
    • Takayama, Nobuyuki;
    • Kinoshita, Tomohiro;
    • Motoji, Toshiko;
    • Ohyashiki, Kazuma;
    • Kosugi, Hiroshi;
    • Matsuda, Shin;
    • Ohnishi, Kazunori;
    • Omachi, Ken;
    • Hotta, Tomomitsu
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial.

    Published in:
    Angewandte Chemie, 2019, v. 131, n. 15, p. 42, doi. 10.1111/bjh.15741
    By:
    • Böll, Boris;
    • Plütschow, Annette;
    • Bürkle, Carolin;
    • Atta, Johannes;
    • Pfreundschuh, Michael;
    • Feuring‐Buske, Michaela;
    • Vogelhuber, Martin;
    • Sökler, Martin;
    • Eichenauer, Dennis A.;
    • Thielen, Indra;
    • Tresckow, Bastian;
    • Fuchs, Michael;
    • Engert, Andreas;
    • Borchmann, Peter
    Publication type:
    Article
    41

    Bone marrow necrosis in a girl with Hodgkin's disease.

    Published in:
    Supportive Care in Cancer, 2012, v. 20, n. 9, p. 2231, doi. 10.1007/s00520-012-1502-z
    By:
    • Lackner, Herwig;
    • Strenger, Volker;
    • Sovinz, Petra;
    • Beham-Schmid, Christine;
    • Pilhatsch, Alexander;
    • Benesch, Martin;
    • Schwinger, Wolfgang;
    • Ulreich, Raphael;
    • Schmidt, Sandrin;
    • Urban, Christian
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50